Biogen Pharmachem Industries Limited

Biogen Pharmachem Issues postal ballot notice for three ordinary resolutions including a 1:6 bonus share issue capitalizing ₹17 crore from share premium. Authorized share capital proposed to increase

Biogen Pharmachem's board approved a 1:6 bonus issue of 15,04,33,833 equity shares funded from securities premium. Authorized share capital to increase from Rs. 91 crore to Rs. 108 crore, subject to s

Biogen Pharmachem clarified to BSE that Reg 30 disclosures for auditor resignation and appointment were already filed on 09.02.2026 and 10.02.2026. M/s Rishi Sekhri & Associates (Membership No. 126656